ISENTRESS
Active substance: raltegravir
TABLET, FILM COATED · RALTEGRAVIR POTASSIUM 400 mg/1
United StatesActive
Marketing holder: NuCare Pharmaceuticals,Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- RALTEGRAVIR POTASSIUM · 400 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 22 |
|
| EU 3 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-5042-705a-9204-5b81685321e5,01a1208c-52ca-7876-848b-7404948f5955,01a1208e-1c9c-741e-aef2-ada6097022bf,01a1208e-56c2-77bc-81a5-2d03b9c71297,01a1208e-b7f5-7e48-b5cd-dbd829ad5ece;count=9 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 68071-2113
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 68071-2113 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 68071-2113 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 68071-2113 · Verified 2026-10-09 · open in source